financetom
Business
financetom
/
Business
/
UDR Says Chief Investment Officer Retiring
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UDR Says Chief Investment Officer Retiring
Mar 14, 2024 2:26 PM

04:57 PM EDT, 03/14/2024 (MT Newswires) -- UDR (UDR) said late Thursday that Chief Investment Officer Harry Alcock will retire, effective July 31, and will transition to a consulting position with a focus on transactions.

H. Andrew Cantor, senior vice president - acquisitions and dispositions, will keep overseeing its transactions platform, the firm said, adding that Bob McCullough, senior vice president - development, will continue to oversee its development platform.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cadence Bank Q3 Adjusted Earnings, Revenue Rise
Cadence Bank Q3 Adjusted Earnings, Revenue Rise
Oct 20, 2025
04:52 PM EDT, 10/20/2025 (MT Newswires) -- Cadence Bank ( CADE ) reported Q3 adjusted earnings late Monday of $0.81 per diluted share, up from $0.73 a year earlier. Analysts polled by FactSet expected $0.77. Revenue, expressed as the sum of net interest income and total noninterest income, for the quarter ended Sept. 30 rose to $517.2 million from $447.4...
General Dynamics gets $3.5 billion scout vehicle contract from Germany
General Dynamics gets $3.5 billion scout vehicle contract from Germany
Oct 20, 2025
(Reuters) -General Dynamics ( GD ) said on Monday that its Europe unit has secured a contract for about 3 billion euros ($3.50 billion) to deliver next-generation reconnaissance vehicle for the German Army Reconnaissance Corps. The contract was commissioned to General Dynamics European Land Systems by the Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support (BAAINBw). The company...
Teva, Prestige Biopharma Sign Deal to Commercialize Tuznue Cancer Biosimilar in Europe
Teva, Prestige Biopharma Sign Deal to Commercialize Tuznue Cancer Biosimilar in Europe
Oct 20, 2025
04:51 PM EDT, 10/20/2025 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) said Monday it entered into a licensing and supply agreement with Prestige Biopharma to market Tuznue, a biosimilar to Herceptin, also known as trastuzumab, in most European markets. Tuznue, approved by the European Commission in September 2024, is indicated for HER2-positive breast and metastatic gastric cancers, Teva...
Columbia Financial Q3 Earnings, Revenue Rise
Columbia Financial Q3 Earnings, Revenue Rise
Oct 20, 2025
04:53 PM EDT, 10/20/2025 (MT Newswires) -- Columbia Financial ( CLBK ) reported Q3 earnings late Monday of $0.15 per diluted share, up from $0.06 a year earlier. Two analysts polled by FactSet expected $0.13. Revenue, expressed as the sum of net interest income and total noninterest income, for the quarter ended Sept. 30 was $67.3 million, up from $54.3...
Copyright 2023-2026 - www.financetom.com All Rights Reserved